Please login to the form below

Not currently logged in
Email:
Password:

anti-inflammatory

This page shows the latest anti-inflammatory news and features for those working in and with pharma, biotech and healthcare.

Regeneron and Teva close gap on rivals with NGF pain drug

Regeneron and Teva close gap on rivals with NGF pain drug

therapeutic choices to treat their chronic pain, other than with non-steroidal anti-inflammatory drugs or opioids," said Yancopolous.

Latest news

More from news
Approximately 1 fully matching, plus 134 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2015 Deal Watch October 2015

    Under the agreement Janssen has an option to license enGene's lead candidate, EG-12, for the gut-localised expression of the anti-inflammatory cytokine IL-10 in indications such as ... Up to 3 anti-PD-1 based bispecific antibodies for oncology. Expansion

  • Pharma deals during December 2014 Pharma deals during December 2014

    J&J has been busy entering into licences and research collaborations on the one hand, while exercising an opt-out and terminating its $945m anti-inflammatory deal with Astellas that was ... In early December, Merck added more weight to its

  • Investing in the future of R&D Investing in the future of R&D

    The anti-inflammatory TNF drug, whose indications currently include rheumatoid arthritis and Crohn's disease, became UCB's leading product in the first half of 2014, thanks to 23% growth in ... This was followed in March by a drug discovery and

  • Back to the future Back to the future

    The best-selling biologic - and still pharma's biggest global brand - is Humira, AbbVie and Eisai's anti-inflammatory drug.

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    167. UCB/ Sanofi. Collaboration - discovery/ development. Anti-inflammatory small molecules for treatment of immune-mediated disorders (discovery). ... 23. Genmab/ Janssen. Milestone payment. Daratumumab, anti-CD38 mAb for multiple myeloma (p2 milestone).

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics